全基因组测序NIPS覆盖全胎儿分数范围的临床经验
该研究回顾性分析58 105例单胎妊娠在定制全基因组测序平台上的无创产前筛查结果,评估21、18、13三体的检测性能。该筛查方法无需胎儿分数阈值即可达到高准确性,检测失败率为0.1%,若采用4%胎儿分数阈值则检测失败率升至6.6%。
要点
- 58 105例单胎中99.9%获得检测结果,检测失败率约0.1%。
- 21、18、13三体推断灵敏度分别为99.7%、96.8%、94.3%。
- 若采用4%胎儿分数阈值,检测失败率将升至6.6%。
核心结论
- 基于定制全基因组测序的无创产前筛查不设胎儿分数阈值即可实现高准确性,同时维持0.1%的低检测失败率。
研究设计与样本
- 回顾性分析8个月期间在定制全基因组测序平台接受无创产前筛查的58 105例单胎妊娠,评估21、18、13三体检测性能,并对所有筛查阳性者及18%筛查阴性者追踪妊娠结局。
主要发现
- 筛查检测对99.9%(n=58 048)的患者给出结果,检测失败率0.1%;获得结果的妊娠中572例(1%)筛查阳性,其中21三体362例、18三体142例、13三体68例。
- 筛查阳性患者中237例(41.4%)获得信息性结局,筛查阴性患者中3258例(5.7%)获得信息性结局。
- 全队列中21、18、13三体的推断灵敏度分别为99.7%、96.8%、94.3%,阳性预测值分别为93.1%、85.2%、48.4%。
- 若采用4%胎儿分数阈值以防范假阴性,三种非整倍体的计算灵敏度不会显著改变,但总体检测失败率将升至6.6%(n=3829),影响1/15的女性。
关键数值与推荐
- 推断灵敏度:21三体99.7%、18三体96.8%、13三体94.3%;阳性预测值:21三体93.1%、18三体85.2%、13三体48.4%。
- 4%胎儿分数阈值条件下检测失败率为6.6%(n=3829),每15名女性中影响1名。
临床怎么用
- 对于该筛查方法,为确保低胎儿分数样本中常见非整倍体高检出准确性的替代策略(如检测失败后重抽、稍后孕周重抽、基于胎儿分数的风险评分)并不必要。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe our clinical experience across the entire range of fetal-fraction (FF) measurements of a non-invasive prenatal screen (NIPS) that uses whole- genome sequencing (WGS). METHODS: We analyzed retrospectively results from 58 105 singleton pregnancies that underwent NIPS on a customized WGS platform during an 8-month period and assessed clinical test performance for trisomy 21, trisomy 18 and trisomy 13. Pregnancy outcomes were sought for all screen-positive patients and for 18% of screen-negative patients. As differences in outcome-collection response rates could artificially impact test-performance calculations, we computed inferred sensitivity, specificity, positive predictive values (PPV) and negative predictive values adjusted for ascertainment bias. RESULTS: The screening test yielded a result for 99.9% (n = 58 048) of patients, meaning that approximately 1 in 1000 patients received a test failure (i.e. test failure rate = 0.1%). Of pregnancies with a test result, 572 (1%) screened positive for one of the common aneuploidies (362 for trisomy 21, 142 for trisomy 18 and 68 for trisomy 13). Informative outcomes were received for 237 (41.4%) patients with a screen-positive result and 3258 (5.7%) of those with a screen-negative result. In the full cohort, inferred sensitivities for trisomy 21, trisomy 18 and trisomy 13 were 99.7%, 96.8% and 94.3%, respectively, and PPVs were 93.1%, 85.2% and 48.4%, respectively. If a FF threshold of 4% had been employed to guard against false negatives, calculated sensitivities for the three aneuploidies would not have changed significantly, yet, importantly, the overall test-failure rate would have increased to 6.6% (n = 3829), impacting 1 in 15 women. CONCLUSIONS: Our clinical experience demonstrates that a customized WGS-based NIPS without a FF threshold achieves high accuracy while maintaining a low test-failure rate of 0.1%. As such, alternative strategies to ensure high accuracy of detection of common aneuploidies in samples with low FF (such as redraw after test failure, redrawing at a later gestational age, risk scoring based on FF) are not necessary for this screening approach. © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Hancock S, Ben-Shachar R, Adusei C, et al. Clinical experience across the fetal-fraction spectrum of a non-invasive prenatal screening approach with low test-failure rate. Ultrasound Obstet Gynecol. 2020. PMID: 31671482. doi:10.1002/uog.21904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。